Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Need Help Injecting Your Medication
It was first characterized by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, and a 2025 literature and patent review cataloged its effects across gastrointestinal, musculoskeletal, and neural models
In contrast to small-molecule compounds, peptide drugs demonstrate pharmacokinetic characteristics of short elimination half-life and poor metabolic stability in vivo
Individuals with pernicious anemia, characterized by a lack of intrinsic factor, are also particularly susceptible
Clinical Trials: Studies have shown that patients receiving BPC-157 therapy experience significant improvements in pain and function
US$ 27.28
US$ 27.10
US$ 25.54
US$ 27.71
US$ 28.79
US$ 25.50
